Raymond James Financial’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.74M Sell
170,831
-10,050
-6% -$276K ﹤0.01% 3008
2026
Q2
$5.78M Sell
180,881
-66,217
-27% -$2.19M ﹤0.01% 2619
2026
Q1
$9.46M Buy
247,098
+77,066
+45% +$2.49M ﹤0.01% 2073
2025
Q4
$4.47M Buy
170,032
+43,658
+35% +$802K ﹤0.01% 2609
2025
Q3
$1.77M Buy
126,374
+63,187
+100% +$720K ﹤0.01% 3259
2025
Q2
$605K Buy
63,187
+8,843
+16% +$84K ﹤0.01% 3891
2025
Q1
$505K Sell
54,344
-439
-0.8% -$5.68K ﹤0.01% 3936
2024
Q4
$761K Buy
+54,783
New +$994K ﹤0.01% 3641

Other funds holding TYRA

Raymond James Financial's TYRA Position: Q3 2026 in Review

Raymond James Financial reduced its Tyra Biosciences (TYRA) stake by 5.6% in Q3 2026, selling an estimated $276K and leaving 170,831 shares worth $3.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Raymond James Financial first reported a position in TYRA in Q4 2024 and has held it in 8 quarters since. The position peaked at $9.46M in Q1 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Raymond James Financial held 170,831 shares of Tyra Biosciences worth $3.74M as of Q3 2026.
  • Raymond James Financial sold 10,050 Tyra Biosciences shares in Q3 2026, an estimated $276K.
  • Tyra Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3008 holding.
  • Raymond James Financial first reported a position in Tyra Biosciences in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Tyra Biosciences position peaked at $9.46M in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.